Tirzepatide (60mg)

Tirzepatide is a lab-made peptide designed to do something two-in-one: it activates two of the body's metabolic "incretin" receptors at the same time — GIP and GLP-1. That dual-action design is exactly why it has become such a closely watched molecule in metabolic research — the field most people know in plain terms as weight-loss research.

Scientists study it as a model for how activating two receptors together behaves differently from activating just one, comparing it against single-receptor GLP-1 compounds and newer triple-receptor designs like retatrutide.

What researchers study it for:

• Dual-receptor pharmacology — how one molecule works on two targets
• Blood-sugar and metabolic models — the core research area
• Insulin-signaling research — how the two receptors combine
• Comparative studies — versus single- and triple-agonist molecules

Everything here reflects published trial and preclinical research and is provided for educational, research-use-only purposes. It is not for human consumption.

In receptor-pharmacology work, the value of a dual agonist rests entirely on it being pure and correctly identified; a mislabeled or contaminated sample can quietly derail an experiment before it starts. Each batch here is verified by an independent laboratory and traceable to its lot, so the molecule you study is genuinely the molecule you ordered. It is typically supplied as a lyophilized powder for stability.

For the full science with published studies and citations, read our tirzepatide research overview.

Every batch is tested by an independent, accredited laboratory and ships with a batch-matched Certificate of Analysis (COA) you can verify before buying — confirmed at 99% purity. For research use only. Not for human or animal consumption.